Letter to the editor

Journal of General Internal Medicine

Volumn 17, Issue 1, 2002, Pages 85-

  Cundiff, David K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; PHENYLBUTAZONE;

ANTICOAGULATION; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; LETTER; LUNG EMBOLISM; PROPHYLAXIS; TREATMENT INDICATION;

EID: 0036164966     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.2002.11138.x     Document Type: Letter

References (9)

1. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism
2. Inadequacy of intravenous heparin therapy in the initial management of venous thromboembolism
3. Use of low malecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin trial
4. Low molecular weight heparins
5. Oral anticoagulation in venous thromboembolism: Decisions based on more than mere feelings
6. A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis
7. A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography: Potential for an improvement in the diagnostic process
8. Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation
9. Anticoagulant therapy in deep venous thrombosis. A randomized controlled study